placeholder
Importance
45
Trust
71
Urgency
30
COMMERCIAL
GLP-1 Market to Reach $180 Billion by 2035 at 8.7% CAGR | Novo Nordisk, Eli Lilly, Pfizer Among Key Players - openPR.com
Analysis
A market report says GLP-1 drug sales could hit $180 billion by 2035. That points to years of strong growth for Novo and Lilly.
- GLP-1 market projected to reach $180 billion by 2035
- Forecast assumes 8.7% compound annual growth rate
- Novo Nordisk, Eli Lilly, and Pfizer named as key players
Novo Nordisk News1mo
Read